Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force
British Journal of Haematology, 152, 35–51
Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy
18:19
סגור לתגובות על Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy
BLOOD, 4 NOVEMBER 2010, VOLUME 116, NUMBER 18
How I treat Philadelphia chromosome positive acute lymphoblastic leukaemia
14:25
סגור לתגובות על How I treat Philadelphia chromosome positive acute lymphoblastic leukaemia
Adele K. Fielding
Blood 2010 :blood-2010-01-242750
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
16:57
אין תגובות
Alice L. Yu, M.D., Ph.D et al.,
N Engl J Med 2010; 363:1324-1334
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
16:31
אין תגובות
Alice L. Yu, M.D., Ph.D. et al.
N Engl J Med 2010; 363:1324-1334
AEWS07P1 – A Pilot Study of Chemotherapy Intensification by Adding Vincristine, Topotecan and Cyclophosphamide to Standard Chemotherapy Agents with an Interval Compression Schedule in Newly Diagnosed Patients with Localized Ewing Sarcoma Family of Tumors
13:13
אין תגובות
STUDY CHAIR
Leo Mascarenhas, M.D.
Recent Advances in Neuroblastoma
16:49
אין תגובות
John M. Maris, M.D
N Engl J Med 2010; 362:2202-2211
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
12:05
סגור לתגובות על Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
Cairo, M. S., Coiffier, B. , Reiter, A. , Younes, A. on behalf of the TLS Expert Panel,
British
AGCT0132 | A PHASE III STUDY OF REDUCED THERAPY IN THE TREATMENT OF CHILDREN WITH LOW AND INTERMEDIATE RISK EXTRACRANIAL GERM CELL TUMORS
12:29
אין תגובות
STUDY CHAIR: A. Lindsay Frazier, M.D., Sc.M.
EsPhALL: Amendment proposal
14:08
אין תגובות
An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+
